215 related articles for article (PubMed ID: 34893803)
1. Contributions of obesity to kidney health and disease: insights from Mendelian randomization and the human kidney transcriptomics.
Xu X; Eales JM; Jiang X; Sanderson E; Drzal M; Saluja S; Scannali D; Williams B; Morris AP; Guzik TJ; Charchar FJ; Holmes MV; Tomaszewski M
Cardiovasc Res; 2022 Dec; 118(15):3151-3161. PubMed ID: 34893803
[TBL] [Abstract][Full Text] [Related]
2. Allometric body shape indices, type 2 diabetes and kidney function: A two-sample Mendelian randomization study.
Kjaergaard AD; Krakauer J; Krakauer N; Teumer A; Winkler TW; Ellervik C
Diabetes Obes Metab; 2023 Jul; 25(7):1803-1812. PubMed ID: 36855799
[TBL] [Abstract][Full Text] [Related]
3. Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study.
Lyall DM; Celis-Morales C; Ward J; Iliodromiti S; Anderson JJ; Gill JMR; Smith DJ; Ntuk UE; Mackay DF; Holmes MV; Sattar N; Pell JP
JAMA Cardiol; 2017 Aug; 2(8):882-889. PubMed ID: 28678979
[TBL] [Abstract][Full Text] [Related]
4. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
[TBL] [Abstract][Full Text] [Related]
5. Obesity, Type 2 Diabetes, Lifestyle Factors, and Risk of Gallstone Disease: A Mendelian Randomization Investigation.
Yuan S; Gill D; Giovannucci EL; Larsson SC
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e529-e537. PubMed ID: 33418132
[TBL] [Abstract][Full Text] [Related]
6. Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study.
Richardson TG; Sanderson E; Elsworth B; Tilling K; Davey Smith G
BMJ; 2020 May; 369():m1203. PubMed ID: 32376654
[TBL] [Abstract][Full Text] [Related]
7. Does Obesity Cause Thyroid Cancer? A Mendelian Randomization Study.
Fussey JM; Beaumont RN; Wood AR; Vaidya B; Smith J; Tyrrell J
J Clin Endocrinol Metab; 2020 Jul; 105(7):e2398-407. PubMed ID: 32392279
[TBL] [Abstract][Full Text] [Related]
8. The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study.
Yang Y; Xian W; Wu D; Huo Z; Hong S; Li Y; Xiao H
Front Endocrinol (Lausanne); 2022; 13():917056. PubMed ID: 35992130
[TBL] [Abstract][Full Text] [Related]
9. Assessing causal associations of obesity and diabetes with kidney stones using Mendelian randomization analysis.
Yuan S; Larsson SC
Mol Genet Metab; 2021; 134(1-2):212-215. PubMed ID: 34454843
[TBL] [Abstract][Full Text] [Related]
10. Obesity and risk of female reproductive conditions: A Mendelian randomisation study.
Venkatesh SS; Ferreira T; Benonisdottir S; Rahmioglu N; Becker CM; Granne I; Zondervan KT; Holmes MV; Lindgren CM; Wittemans LBL
PLoS Med; 2022 Feb; 19(2):e1003679. PubMed ID: 35104295
[TBL] [Abstract][Full Text] [Related]
11. Adiposity, diabetes, lifestyle factors and risk of gastroesophageal reflux disease: a Mendelian randomization study.
Yuan S; Larsson SC
Eur J Epidemiol; 2022 Jul; 37(7):747-754. PubMed ID: 35119566
[TBL] [Abstract][Full Text] [Related]
12. Body Mass Index and Risk of Diabetic Nephropathy: A Mendelian Randomization Study.
Lu J; Liu X; Jiang S; Kan S; An Y; Zheng C; Li X; Liu Z; Xie G
J Clin Endocrinol Metab; 2022 May; 107(6):1599-1608. PubMed ID: 35191949
[TBL] [Abstract][Full Text] [Related]
13. Nonlinear causal effects of estimated glomerular filtration rate on myocardial infarction risks: Mendelian randomization study.
Park S; Lee S; Kim Y; Cho S; Huh H; Kim K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
BMC Med; 2022 Feb; 20(1):44. PubMed ID: 35109828
[TBL] [Abstract][Full Text] [Related]
14. Exploring the causal pathway from bilirubin to CVD and diabetes in the UK biobank cohort study: Observational findings and Mendelian randomization studies.
Hou L; Li H; Si S; Yu Y; Sun X; Liu X; Yan R; Yu Y; Wang C; Yang F; Wang Q; Xue F
Atherosclerosis; 2021 Mar; 320():112-121. PubMed ID: 33485635
[TBL] [Abstract][Full Text] [Related]
15. Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study.
Freuer D; Linseisen J; Meisinger C
Metabolism; 2021 May; 118():154732. PubMed ID: 33631142
[TBL] [Abstract][Full Text] [Related]
16. Childhood obesity leads to adult type 2 diabetes and coronary artery diseases: A 2-sample mendelian randomization study.
Fang X; Zuo J; Zhou J; Cai J; Chen C; Xiang E; Li H; Cheng X; Chen P
Medicine (Baltimore); 2019 Aug; 98(32):e16825. PubMed ID: 31393416
[TBL] [Abstract][Full Text] [Related]
17. Causal effects from non-alcoholic fatty liver disease on kidney function: A Mendelian randomization study.
Park S; Lee S; Kim Y; Cho S; Kim K; Chul Kim Y; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
Liver Int; 2022 Feb; 42(2):412-418. PubMed ID: 34843158
[TBL] [Abstract][Full Text] [Related]
18. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study.
Nordestgaard AT; Thomsen M; Nordestgaard BG
Int J Epidemiol; 2015 Apr; 44(2):551-65. PubMed ID: 26002927
[TBL] [Abstract][Full Text] [Related]
19. Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients.
Qu HQ; Qu J; Glessner J; Hakonarson H
Metabolism; 2022 Apr; 129():155156. PubMed ID: 35101533
[TBL] [Abstract][Full Text] [Related]
20. Causal effects of life course adiposity on chronic kidney disease: a Mendelian randomization study.
Li D; Zou Y
Ann Palliat Med; 2021 Oct; 10(10):10861-10869. PubMed ID: 34763447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
